According to recent studies, Low Testosterone (Low-T) treatment such as AndroGel and other “Low-T” treatments, may increase the risk of heart attacks and strokes in older and middle aged men, especially if they had a history of heart disease. Lawsuits allege the manufacturers of Low-T therapies (uch as Androgel) have a duty to warn patients about the risk of heart attacks and strokes.
A National Cancer Institute study revealed that some men have an increased risk of suffering heart attacks while using prescription testosterone therapies. The study found that men over the age of 65, as well as patients younger than 65 with a history of heart disease, had twice the rate of heart attacks in the three months after beginning testosterone therapy when compared to the year prior to treatment.
Another study published in the Journal of the American Medical Association had similar results, finding that older men had a 29% increase in stroke, heart attack and death when undergoing testosterone therapy.
The link between testosterone and heart attacks also is supported by a 2009 federally-funded research study intended to address whether testosterone gels could help older men build muscle. The study was stopped before it was concluded because researchers noticed that some of the study’s participants were suffering heart attacks and other cardiac problems.
Solberg Stewart Miller is a law firm that brings claims against drug manufacturers who market “dangerous drugs”. Our law firm does not represent the manufacturers of T-Gel, Androgel or any Testosterone drug but rather is investigating potential lawsuits against T-Gel, Androgel, Testostorone drugs in North Dakota and Minnesota as well as other states.
At Solberg Stewart Miller, in pharmaceutical cases we charge no fees or expenses unless our clients make a recovery. For further information from North Dakota and Minnesota attorneys investigating T-Gel, Androgel, Testosterone contact Mike Miller at Email Testosterone Attorney or call 1.877.237.3166 (toll free) or 237.3166 (Fargo).